×

[Comment] Who is responsible for the vaccination of migrants in Europe?

A report from WHO exploring the provision of immunisation services to migrants and refugees in the WHO European Region1 provides a stark reminder that European health services are a long way off adapting to the rapid demographic shift that the region has witnessed in the past two decades, amid unprecedented rises in internal and external migration. Migrants are more likely to be under-immunised—putting them at increased risk of vaccine-preventable diseases circulating in Europe—and may face greater disease, disability, and deaths from vaccine-preventable diseases than the host population.

[Correspondence] Port-of-Spain Declaration for global NCD prevention

As global health researchers who work on non-communicable diseases (NCDs) and global health diplomacy, we were delighted to see the prioritisation of and emphasis on a global commitment to tackle the epidemic of NCDs in the Comment1 by Sania Nishtar (Oct 21, p 1820). Nishtar suggests excellent strategies, such as a multi stakeholder structure to serve as a holistic platform, to enable transparency and accountability to negotiate policy space for NCDs. Nishtar also highlights that none of the more than 80 disease-specific partnerships that have been created holistically address NCDs, and that this requires a multisectoral, partnership-based solution.

[Comment] What proportion of older adults in hospital are frail?

Despite the increasing level of knowledge about individual illnesses, modern health-care systems seem lost when seeing patients whose diseases come not one at a time, but all at once—especially when they come with equally complex social needs. Although some geriatricians proclaimed the end of the disease era1 to focus on the complexity of frailty in geriatric assessment,2 the argument is falling flat. Disease-focused specialists who push on with the only course they know sometimes decry their frail patients as being unsuitable or requiring social support or failing to cope or thrive.

[Comment] The emerging Chinese COPD epidemic

Few people today question the global burden of chronic respiratory diseases, of which chronic obstructive pulmonary disease (COPD) is the most prominent cause of disability-adjusted life-years.1 Tobacco smoking, poverty, and exposure to biomass fuel are the most important risk factors for COPD globally, and which are unevenly spread.2

[Editorial] Addressing decreasing vaccine coverage in the EU

In recent years, the European Union (EU) has seen large outbreaks of vaccine-preventable diseases such as measles due to declining vaccine coverage, supply shortages, and growing vaccine hesitancy. To address the challenges facing vaccination programmes, the European Commission set an ambitious goal: to put together a Recommendation to strengthen cooperation against vaccine-preventable diseases in EU countries. A roadmap for the Recommendation was published on Dec 4, 2017, and was opened for public consultation for 4 weeks.

[Department of Error] Department of Error

Cohen AJ, Brauer M, Burnett R, et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet 2017; 389: 1907–18—In this Article (published online first on April 10, 2017), the mathematical form for the IER has been corrected. This correction has been made to the online version as of April 19, 2018.

Doctors invited to subscribe to new Olive Wellness Institute

A new online resource promoting the health attributes of extra virgin olive oil has been launched to coincide with the latest international findings of the benefits of a Mediterranean diet.

The world-first Olive Wellness Institute aims to build awareness of olive products through the gathering, sharing and promotion of credible, evidence-based information pertaining to their nutrition, and health and wellness benefits.

The Institute, which is sponsored by olive company Boundary Blend Limited, is asking doctors to subscribe to its free online research source.

Professor Catherine Itsiopoulos, Head of the School of Allied Health at La Trobe University, chairs the Olive Wellness Institute’s (OWI) advisory panel.

“Given the abundant misinformation on the health benefits of foods, ingredients and supplements, a collaborative organisation like the OWI will offer healthcare professionals, scientists, academics and members of the general public, invaluable access to evidence-based information about extra virgin olive oil (EVOO) and other olive products,” she said.

“I have been researching the impact of the Mediterranean diet for more than 20 years, and EVOO forms the basis of the dietary advice I provide to patients with heart disease, diabetes and other chronic diseases.”

Prof Itsiopoulos is currently conducting a trial which aims to demonstrate the positive effects of the Mediterranean diet on patients with coronary heart disease.

A new research review, published last month in the Journals of Gerontology and titled The Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms, highlights the anti-inflammatory and antioxidant properties of phytochemicals found in EVOO.

Conducted by US and Italian geriatric and nutritional research scientists, the review discusses the role played by EVOO and the Mediterranean diet in trying to reduce the risk of stroke, Type 2 diabetes, peripheral artery disease and breast cancer.

Subscription to the olive wellness community is free via the OWI website: www.olivewellnessinstitute.org.

Subscribers can access:

  • Regularly updated news and articles relating to olive nutrition, health and wellness.
  • An easily searchable and comprehensive olive science database featuring prominent recent research findings.
  • An expert library listing designed to facilitate queries and research collaboration.
  • A list of relevant olive events worldwide.

New subscribers can also download a free olive health and wellness e-book, containing comprehensive information about the history and science behind olive products.

CHRIS JOHNSON

Scanning on top of the world

Radiographic imaging equipment has been delivered to the top of the world – almost.

Kunde hospital is located 24.6 kilometres from Mount Everest Base Camp and a Carestream Vita Flex CR System was recently delivered and installed there by Capital Enterprises.

The equipment provides imaging services to 8,000 local residents as well as mountaineers, sherpas and others who support those who attempt to climb Mount Everest.

The imaging system was transported by plane to Lukla, Nepal. The Lukla airport (officially called the Tenzing-Hillary Airport) is regarded by many as the world’s deadliest airport due to its high elevation and unforgiving terrain.

From there, porters carried the x-ray equipment on their backs for 30 kilometres to the hospital, which is staffed and operated by local physicians and nurses.

The system is used by medical staff to capture digital x-ray images of shoulders and extremities that have been broken or sprained.

It is also for the head and neck area to diagnose sprains or concussions; as well as chest exams that may indicate a patient has pneumonia, altitude sickness, or evidence of a heart attack or other serious medical conditions.

These imaging studies are essential to diagnosing diseases and injuries to climbers, sherpas and other workers at base camp.

“The images are available in minutes and physicians decide if a patient can be treated at the hospital or must be transported to Kathmandu… by helicopter or airplane,” said Carestream’s Charlie Hicks.

Kathmandu is 136 kilometres from Kunde Hospital. The Kunde hospital, which was founded by Sir Edmund Hillary in 1966, is 3,840 metres above sea level.

CHRIS JOHNSON

 

[Comment] The Lancet Commission on malaria eradication

20 years ago, infectious diseases dominated the global health agenda. Policy makers, researchers, implementers, and donors united in the fight against infectious diseases, creating the Millennium Development Goals, the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gavi, the Vaccine Alliance, the US President’s Emergency Plan For AIDS Relief (PEPFAR), the Roll Back Malaria Partnership, the Multilateral Initiative on Malaria (MIM),1 and more. Tremendous progress was made. Malaria benefited spectacularly and there has been a 47% reduction in global deaths from the disease since 2000.

Australia’s flesh-eating bug outbreak needs an urgent response

 

Victoria is facing a worsening epidemic of flesh-eating bacteria that cause a disease known internationally as Buruli ulcer – and we don’t know how to prevent it. Also called Bairnsdale ulcer or Daintree ulcer, this disease causes destructive skin lesions that can lead to severe illness and occasionally even death.

Buruli ulcer is caused by the bacteria Mycobacterium ulcerans (M. ulcerans) and often results in long-term disability and cosmetic deformity.

An epidemic, or an outbreak, is when cases of a disease occur more often than expected in a given area over a particular period of time.

In 2016, there were 182 new cases in Victoria, which, at the time was the highest number ever reported. But the number of casesreported in 2017 (275) have further increased by 51%, compared with 2016 (182). The cases are also becoming more severe in nature and occurring in new geographical areas.

In Australia, Buruli ulcer is frequently reported from the Daintree region, and less commonly the Capricorn coast, of Queensland. Occasionally we’ve heard of cases from the NT, NSW and WA. But most reports come from Victoria, where the disease has been recognised since 1948.

Despite this, we still don’t know the exact environmental niche where the organism lives and how it is transmitted to humans.

Our article, published today in the Medical Journal of Australia, calls for an urgent investigation to answer some critical questions. These include finding out the natural source of M. ulcerans; how the infection is transmitted to humans; what role possums, mosquitoes and other species play in transmission; why the disease incidence is increasing and spreading into new areas in Victoria; and why cases are becoming more severe.

Why is Buruli ulcer such a problem?

Buruli ulcer occurs most commonly in the tropical regions of West or Central Africa, and is a significant public health problem there.

Ulcers are the most common form of this disease. But it can also manifest as a small swelling or lump below the skin, a plaque or as a cellulitic form, and can be complicated by bone or joint infection. The disease can affect all age-groups, including young children.

Treatment effectiveness has improved in recent years and cure rates have approached 100% with the use of combination antibiotics (rifampicin and clarithromycin). But these are expensive and not subsidised under Australia’s Pharmaceutical Benefits Scheme (PBS).

The treatments are also powerful and about one-quarter of people have severe side-effects including hepatitis, allergy or a destabilisation of other medical conditions such as heart disease or mental illness.

Many people require reconstructive plastic surgery – sometimes with prolonged hospital admissions. On average it takes four to five months for the disease to heal, and sometimes a year or more.

All of this results in substantial costs through such things as wound dressings, medical visits, surgery, hospitalisation, and time off work or school.

What do we know about the bacteria?

M. ulcerans disease is concentrated in particular sites, and endemic and non-endemic areas are separated by only a few kilometres. In Africa it’s usually associated with wetlands, especially those with slow-flowing or stagnant waters. But in Australia it’s found mostly in coastal regions, like Victoria’s Mornington Peninsula.

We know the risk of infection is seasonal, with an increased risk in the warmer months. Lesions most commonly occur on areas of the body that have been exposed. This suggests bites, environmental contamination or trauma may play a role in infection, and that clothing is protective.

Human-to-human transmission does not seem to occur, although cases are commonly clustered in families, presumably as a result of similar environmental exposure.

The rest is unclear. Possible sources of infection in the environment include the soil, or dead plant material in water bodies such as lakes or ponds.

It may be transmitted to humans though contamination of skin lesions and minor abrasions – through trauma or via the bite of insects such as mosquitoes.

In Victoria, some possums in Point Lonsdale on the Bellarine Peninsula (an endemic area) were found to have Buruli ulcers and have high levels of M. ulcerans in their faeces. The location, proportion and concentration of M. ulcerans in possum faeces was also strongly correlated with human cases. But no M. ulcerans was found in possum faeces in nearby areas with no human cases.

So, it’s thought possum faeces might increase the risk of infection to humans in contact with that environment, or infection could be potentially transmitted by insects biting possums and then humans.

What should we do?

We need to understand the risk factors for M. ulcerans disease by comprehensively analysing human behaviour and environmental characteristics, combined with information on climate and geography.

It’s especially relevant that over the last two years, the number of cases have been increasing in the Mornington Peninsula, while decreasing in the adjacent Bellarine Peninsula. Studying this could allow us to pinpoint the risk factors that underlie the differing incidence patterns.

Once identified, more specific analysis can be performed to further assess the role of these risk factors. We can then explore targeted interventions such as modifying human behaviour, insect control, changes to water use and informed urban planning. Through this we have the best chance to develop effective public health interventions to prevent the disease, and promote more community education and awareness campaigns to help people protect themselves.

It will also facilitate the development of predictive models for non-affected areas that closely monitor these areas for the emergence of the organism. This knowledge can hopefully also be applied globally to benefit those affected overseas.

The ConversationWe need an urgent response based on robust scientific knowledge. Only then can we hope to halt the devastating impact of this disease. We advocate for local, regional and national governments to urgently commit to funding the research needed to help stop Buruli ulcer.

Daniel O’Brien, Associate Professor, University of Melbourne

This article was originally published on The Conversation. Read the original article.